Follow
Mo Huang
Mo Huang
Associate Principal Scientist, Biostatistics, Merck
Verified email at merck.com - Homepage
Title
Cited by
Cited by
Year
SAVER: gene expression recovery for single-cell RNA sequencing
M Huang, J Wang, E Torre, H Dueck, S Shaffer, R Bonasio, JI Murray, ...
Nature Methods 15 (7), 539-542, 2018
6462018
Systematic analysis of splice-site-creating mutations in cancer
RG Jayasinghe, S Cao, Q Gao, MC Wendl, NS Vo, SM Reynolds, Y Zhao, ...
Cell reports 23 (1), 270-281. e3, 2018
2182018
Data Denoising with transfer learning in single-cell transcriptomics
J Wang, D Agarwal, M Huang, G Hu, Z Zhou, C Ye, NR Zhang
Nature Methods 16 (9), 875-878, 2019
1642019
Gene expression distribution deconvolution in single-cell RNA sequencing
J Wang, M Huang, E Torre, H Dueck, S Shaffer, J Murray, A Raj, M Li, ...
Proceedings of the National Academy of Sciences 115 (28), E6437-E6446, 2018
1232018
Design of an expression system to enhance MBP-mediated crystallization
T Jin, W Chuenchor, J Jiang, J Cheng, Y Li, K Fang, M Huang, P Smith, ...
Scientific reports 7, 40991, 2017
522017
MicrobiomeExplorer: an R package for the analysis and visualization of microbial communities
J Reeder, M Huang, JS Kaminker, JN Paulson
Bioinformatics 37 (9), 1317-1318, 2021
222021
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
JS Weber, MS Carlino, A Khattak, T Meniawy, G Ansstas, MH Taylor, ...
The Lancet 403 (10427), 632-644, 2024
192024
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study
GP Gregory, S Kumar, D Wang, D Mahadevan, P Walker, ...
Blood advances 6 (4), 1232-1242, 2022
182022
The structure of the CARD8 caspase-recruitment domain suggests its association with the FIIND domain and procaspases through adjacent surfaces
T Jin, M Huang, P Smith, J Jiang, TS Xiao
Acta Crystallographica Section F: Structural Biology and Crystallization …, 2013
172013
Structure of the caspase-recruitment domain from a zebrafish guanylate-binding protein
T Jin, M Huang, P Smith, J Jiang, TS Xiao
Acta Crystallographica Section F: Structural Biology and Crystallization …, 2013
132013
Dimension reduction and denoising of single-cell RNA sequencing data in the presence of observed confounding variables
M Huang, Z Zhang, NR Zhang
bioRxiv, 2020.08. 03.234765, 2020
112020
Crystal structure of human NLRP12 PYD domain and implication in homotypic interaction
T Jin, M Huang, J Jiang, P Smith, TS Xiao
PloS one 13 (1), e0190547, 2018
102018
73P Association between homologous recombination repair mutations and response to pembrolizumab (pembro) plus olaparib (ola) in metastatic castration-resistant prostate cancer …
E Yu, JM Piulats, G Gravis, P Fong, T Todenhöfer, B Laguerre, J Arranz, ...
Annals of Oncology 32, S387, 2021
82021
BreakPoint Surveyor: a pipeline for structural variant visualization
MA Wyczalkowski, KM Wylie, S Cao, MD McLellan, J Flynn, M Huang, ...
Bioinformatics 33 (19), 3121-3122, 2017
52017
Phase 1b study of pan‐AKT inhibitor vevorisertib alone or with paclitaxel or fulvestrant in PIK3CA/AKT/PTEN‐mutated advanced solid tumors
S Pant, E Hamilton, SV Ulahannan, JF Strauss, FS Braiteh, M Huang, ...
Cancer 129 (12), 1919-1929, 2023
22023
Phase 1b Trial of Anti-Immunoglobulin-like Transcript 3 Monoclonal Antibody MK-0482 Monotherapy in Relapsed/Refractory Acute Myeloid Leukemia and Chronic Myelomonocytic Leukemia
GC Issa, D Lavie, A Przespolewski, SK George, M Huang, M Chen
Blood 140 (Supplement 1), 11759-11760, 2022
12022
Online Single-cell RNA-seq Data Denoising with Transfer Learning
B Kang, E Abeysinghe, D Agarwal, Q Wang, S Pamidighantam, M Huang, ...
Practice and Experience in Advanced Research Computing, 469-472, 2020
12020
A Statistical Framework for Denoising Single-cell RNA Sequencing Data
M Huang
University of Pennsylvania, 2020
12020
Statistical Interpretation and Comparison of Waterfall Plots
M Huang, C Chen, LZ Sun
JCO Clinical Cancer Informatics 7, e2300132, 2023
2023
116TiP KEYNOTE-B98: Phase Ib/II study of pembrolizumab plus investigational agents as second-line treatment for anti–PD-1/PD-L1-refractory extensive-stage small cell lung …
WCV Lai, MJ Ahn, T Shentzer, D Kowalski, BC Cho, S Schmid, M Jové, ...
Annals of Oncology 32, S1425-S1426, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20